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Stellingen behorend bij het proefschrift
IMMUNE-BASED THERAPIES IN OVARIAN CANCER
1. IL-6 and IL-6R are opposite markers for myeloid cell infiltration and survival. this thesis
2. Gemcitabine treatment decreases myeloid derived suppressor cells in humans. this thesis
3. IL-6R blocking, in combination with chemotherapy, has an acceptable safety profile and 
a possible immunological benefit in patients with recurrent ovarian cancer. this thesis
4. Gemcitabine treatment, immune modulation with Pegintron and therapeutic 
vaccination is a well-tolerated approach in the development of combined chemo-
immunotherapeutic regimens to treat cancer. this thesis
5. The success of combining different forms of immunotherapy and chemotherapy de-
pends on our ability to optimize the dose and schedule of the combination regimen  
and to manage its toxicity. this thesis
6. Chemotherapies and immunotherapies must be combined effectively to attack the 
tumor from multiple sides to quickly and thoroughly eliminate cancer (GM Weir, Can-
cers 2011 Aug 5;3(3):3114-42) necessitating a thorough understanding of the impact of 
each chemotherapeutic compound on the immune system.  
7. While the field of cancer immunotherapy has had a great number of FDA approval for 
immunotherapy, the next crucial step in chasing the costs are future breakthroughs in 
validated biomarker development.
8. Both PITCH and CHIP are subtle shots to reach the final target.
9. In life as in career, it are our choices that show what we truly are, far more than our 
abilities. Albus Dumbledore, Harry Potter and the Chamber of Secrets (1998)
10. He who has never changed his opinion has rarely learned anything. loosely translated 
from slogan NRC Handelsblad 
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